CareLit Fachartikel

Global Research Output of Lutetium-177 PSMA in Prostate Cancer: Bibliometric and Altmetric Analyses

Rakan Al-Rashdan, Haneen Al-Abdallat, Mike Machaba Sathekge, Siroos Mirzaei, Mohammed Shahait, Khaled Al-Khawaldeh, Ahmed Saad Abdlkadir, Szeting Lee, Akram Al-Ibraheem · Nuklearmedizin - NuclearMedicine · 2024 · Heft 03 · S. 188-198

Dokument
905355
CareLit-ID
Jahr
2024
Publikation
PDF
nein
Metadaten
DOI
ja
zitierfähig

Bibliografische Angaben

Zeitschrift
Nuklearmedizin - NuclearMedicine
Autor:innen
Rakan Al-Rashdan, Haneen Al-Abdallat, Mike Machaba Sathekge, Siroos Mirzaei, Mohammed Shahait, Khaled Al-Khawaldeh, Ahmed Saad Abdlkadir, Szeting Lee, Akram Al-Ibraheem
Ausgabe
Heft 03 / 2024
Jahrgang 63
Seiten
188-198
Erschienen: 2024-06-01 00:00:00
ISSN
0029-5566
DOI
10.1055/a-2221-3036

Zusammenfassung

Abstract Aim The integration of innovative radio-pharmaceutical agents targeting prostate-specific membrane antigen (PSMA) within nuclear medicine has transformed prostate cancer detection and management. This study aims to investigate the present landscape of [177Lu]Lu-PSMA in prostate cancer, elucidating trends, global contributions, scholarly outlets, institutions, and thematic concentrations with an aim to inform forthcoming research endeavors. Methods We systematically probed the Scopus repository for relevant [177Lu]Lu-PSMA literature. An assessment of bibliometric and altmetric data was carried out. Final…

Schlagworte

Prostate Cancer [177Lu]Lu-PSMA radiopharmaceuticals nuclear medicine Radionuclide Therapy SPECT Nuklearmedizin - NuclearMedicine